Healthy volunteers test new Drug's absorption in Early-Stage study
NCT ID NCT07413133
First seen Feb 22, 2026 · Last updated May 22, 2026 · Updated 14 times
Summary
This early-stage study in 40 healthy adults aims to understand how the experimental drug ABBV-8736 moves through the body when given as a shot under the skin compared to an infusion into a vein. Researchers will measure the drug's levels in the blood, safety, and any side effects. Participants must be in good health and are not expected to receive any direct medical benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 280382
Grayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 280481
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.